Differential 14-3-3 sigma DNA methylation and expression in c-myc- and activated H-ras-transformed cells under r- and...

Area of Science:

• Molecular biology
• Cancer research
• Epigenetics

Background:

• 14-3-3 sigma is a mediator of the p53 tumor suppressor.
• Differential expression of 14-3-3 sigma is observed in various cancers, suggesting its role in tumorigenesis.
• DNA methylation is a key epigenetic mechanism influencing gene expression in cancer.

Purpose of the Study:

• To investigate the role of 14-3-3 sigma as a target of r- and K-selection in cancer development.
• To explore the relationship between DNA methylation, 14-3-3 sigma expression, and cancer phenotypes.
• To understand the epigenetic regulation of 14-3-3 sigma in the context of clonal evolution.

Main Methods:

• Cloning of rat 14-3-3 sigma.
• In vitro selection (r- and K-selection) of transformed rat embryo fibroblasts.
• Analysis of DNA methylation patterns and gene expression levels.
• Treatment with 5-aza-2'-deoxycytidine to assess demethylation effects.

Main Results:

• 14-3-3 sigma expression is suppressed by DNA methylation in r-selected cells, mimicking breast cancer findings.
• 14-3-3 sigma is overexpressed and demethylated in K-selected cells, similar to pancreatic cancer patterns.
• 5-aza-2'-deoxycytidine treatment restored 14-3-3 sigma expression in r-selected cells, confirming the role of methylation.
• Pre-selection heterogeneity in methylation and expression suggests a role in clonal evolution.

Conclusions:

• The study demonstrates that 14-3-3 sigma expression is epigenetically regulated by DNA methylation in response to selection pressures.
• Opposing epigenetic regulation of 14-3-3 sigma contributes to distinct cancer phenotypes observed in breast and pancreatic cancers.
• Heterogeneity in 14-3-3 sigma expression and methylation provides a basis for selection and clonal evolution in cancer.